ANI Pharmaceuticals | ANIP - Beneficio Operativo





Beneficio Operativo Cambio Fecha
AbbVie USD 6.72B 1.99B 2026-06
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Canopy Growth CAD -27.47M 14.81M 2026-03
Eli Lilly USD 12.46B 2.68B 2026-06
Emergent BioSolutions USD -218M 69.9M 2023-06
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.24B 171M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Perrigo USD 23.5M 10.1M 2026-06
Sun Pharmaceuticals INR 35.57B 8.05B 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06